Pacific Biosciences of California, Inc. (PACB)

PACB Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for PACB stock have an average target of 2.45, with a low estimate of 1.50 and a high estimate of 4.00. The average target predicts an increase of 122.73% from the current stock price of 1.10.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.50	$2.45	$2.00	$4.00
Change	+36.36%	+122.73%	+81.82%	+263.64%

* Price targets were last updated on Apr 10, 2025.

Analyst Ratings

The average analyst rating for PACB stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	3	3	3	3	3	2
Buy	4	4	4	4	4	3
Hold	8	6	6	6	6	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	13	13	13	13	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $3	Strong Buy	Maintains	$3	+172.73%	Apr 10, 2025
Sung Ji Nam Scotiabank	Scotiabank	Buy Maintains $6 → $2	Buy	Maintains	$6 → $2	+81.82%	Mar 25, 2025
David Westenberg Piper Sandler	Piper Sandler	Hold Reiterates $2.5 → $2	Hold	Reiterates	$2.5 → $2	+81.82%	Feb 20, 2025
Matthew Sykes Goldman Sachs	Goldman Sachs	Hold Maintains $1.75 → $1.5	Hold	Maintains	$1.75 → $1.5	+36.36%	Feb 18, 2025
Mason Carrico Stephens & Co.	Stephens & Co.	Buy Reiterates $2.5	Buy	Reiterates	$2.5	+127.27%	Feb 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

163.45M

Increased by 6.13%

from 154.01M

Revenue Next Year

198.67M

Increased by 21.55%

from 163.45M

EPS This Year

-0.73

from -1.13

EPS Next Year

-0.61

from -0.73

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	78.89M	130.51M	128.30M	200.52M	154.01M	163.45M	198.67M	246.72M
Revenue Growth	-13.20%	65.43%	-1.69%	56.29%	-23.19%	6.13%	21.55%	24.19%
EPS	0.17	-0.89	-1.40	-1.21	-1.13	-0.73	-0.61	-0.48
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	17	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	175.4M	235.2M	306.6M
Avg	163.5M	198.7M	246.7M
Low	151.9M	178.5M	199.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	13.9%	43.9%	54.3%
Avg	6.1%	21.5%	24.2%
Low	-1.4%	9.2%	0.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.68	-0.32	-0.19
Avg	-0.73	-0.61	-0.48
Low	-0.76	-0.69	-0.57

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.